Missouri Lawmaker Charged After Allegedly Selling Fake Stem Cell Treatments
Rep. Tricia Derges is accused of falsely promoting a stem cell treatment that she said could treat various diseases, including COVID-19.
MARION RENAULT and MARSHALL RITZEL
SPRINGFIELD, Mo. (AP) A federal grand jury has indicted a Missouri state legislator on fraud charges after she falsely promoted a treatment she was selling at medical clinics as containing stem cells that could treat various diseases, including COVID-19.
The 20-count indictment unsealed Monday also accuses 63-year-old Rep. Tricia Derges, a Republican from Nixa, Missouri, of illegally providing prescription drugs to clients and making false statements to federal agents investigating the case.
SPRINGFIELD, Mo. (AP) A Missouri state lawmaker indicted on federal fraud charges for falsely promoting a treatment as having stem cells to help with COVID-19 and other illnesses has been stripped of some of her legislative power.
House Speaker Rob Vescovo on Monday removed fellow Republican Rep. Tricia Derges from all her committee assignments after a federal grand jury indicted the Nixa legislator on fraud charges.
She allegedly falsely promoted a treatment she was selling at medical clinics as containing stem cells that could treat various diseases, including COVID-19.
The 20-count indictment unsealed Monday also accuses the 63-year-old of illegally providing prescription drugs to clients and making false statements to federal agents investigating the case.
Missouri state lawmaker stripped of some legislative power after charged for falsely promoting a COVID-19 stem cell treatment chicagotribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagotribune.com Daily Mail and Mail on Sunday newspapers.
Missouri state lawmaker asked to resign after charged for falsely promoting a COVID-19 stem cell treatment courant.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from courant.com Daily Mail and Mail on Sunday newspapers.